DYAI

Dyadic International, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$0.35

Price (1 Year)

$1.26 $0.34

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %12.5 / %30
Non-compliant assets / Total market cap %4.5 / %30
Non-compliant revenue / Total income %4.5 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins.

Website

Analysis (Turkish): DYAI Hissesi Caiz mi, Helal mi? Dyadic International, Inc. Katılım Analizi